Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

Biosimilars bring price pressure, but are they sufficiently used?

When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...

Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system

Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to ...

Drug development creates new challenges for regulators

Column: Why there cannot be a complete cure for cancer – but there is certainly another way!

"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.

The route to vaccines for everyone: “We did not just sit around and wait”

The pandemic was in full swing, and no one knew when or even if a vaccine would come. At that point, the Swedish Minister of Social Affairs called with a propos...

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...

The perfect formula for decision-making

No one has the luxury not to take a decision, writes Helena Strigård at Swedenbio.

Medicinsk chef till Toleranzia

Vidar Wendel-Hansen blir medicinsk chef i Göteborgsbolaget.

Forskare undersökte syrapumpshämmare med datorsimuleringar – gör koppling till demens

Forskare från Karolinska institutet har i en preklinisk studie sett en mekanism som de anser pekar på att långvarig användning av syradämpande läkemedel kan bid...

BrainCool till Japan

Det Lundabaserade medtechbolaget Braincool har tecknat ett distributionsavtal med Fingal Link i Japan.

Gedea får Horizon-pengar

Vill bli alternativ till antibiotika – Hoppas nå marknaden 2021.

Peab-grundarens stiftelse ger 22 miljoner till life science

Nya behandlingmetoder av cancer, blodbrist och herpesvirus, nya tekniker för kartläggning av gener och upptäckt av sårinfektioner och ett växtbaserat järntillsk...

Odlingsmedium för inducerade pluripotenta celler

Cellartis DEF-CS Xeno Free från Takara Clontech är ett robust odlingsmedium.

How to become globally competitive

Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.

Lucy Robertshaw: There is a bio revolution happening right now

Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Kit för enklare beredning av handgjutna geler

De egengjutna gelerna har samma egenskaper som de färdiggjutna och ger användaren tillgång till snabba körningstider och effektiv proteinöverföring.

The best wealth is Health

We are living in a world where wealth more and more is measured in being able to do the things you like and enjoy in life. As the wealth increases in terms of e...

“Register och journalsystem borde vara samma sak”

Sverige ett framgångsrikt land inom medicinsk forskning, men hur ser det ut i dag och hur blir vi världsbäst?

Dansk och svensk life science lyser

Terapeutiska probiotika, data som lagras i DNA och mindre biverkningar för barn med cancer, det var några av ämnena som avhandlades på mötet The future of Swedi...

They’re all doing it – buying drug research

December 12 the time has come for this year's annual partnering meeting Pharma Outsourcing in Stockholm. In Sweden this is a growing business, with Recipharm as...

Fewer visitors but satisfied exhibitors

Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.

Brexit creeping closer – or?

In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.